KORTUC Inc. Closed Financing From AXA Japan to Accelerate Pivotal Phase II Study of Novel Radiosensitizer for Cancer Radiotherapy
LONDON & NEW YORK & TOKYO--(BUSINESS WIRE)--Today KORTUC Inc., a Japanese clinical-stage biopharmaceutical company focusing…